LSTA

Lisata Therapeutics Inc
3.00
-0.08 (-2.6%)

Lisata Therapeutics Inc. (LSTA) Fundamentals

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases.
SHARE INFORMATION
Market Cap$ 23,579,052
Shares Outstanding7,859,684
Float7,776,961
Percent Float98.95%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -7.83
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions63
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months9,388
Institutional Holdings Percent11.9%
Institutional Sold Previous 3 Months27,770
Insider Holdings Date2023-01-31
Insider Bought Previous 3 Months273,000
Insider Holdings Percent16.7
Insider Sold Previous 3 Months18,759
Insider Shares Owned10,096,279
TRADING INFO
52 Week High$ 11.94
52 Week Low$ 2.36
52 Week High Change$ -74.31
21 Day Moving Average$ 3.2769
21 Day Extended Moving Average$ 3.2677
50 Day Moving Average$ 3.4234
50 Day Extended Moving Average$ 3.3498
200 Day Moving Average$ 5.0609
200 Day Extended Moving Average$ 5.3188
10 Day Average Volume6,049
20 Day Average Volume9,311
30 Day Average Volume9,662
50 Day Average Volume11,924
Alpha-0.041398
Beta1.1672
Standard Deviation0.199847
R20.098923
7 Day Price Change$ -0.31
7 Day Percent Change-9.37%
21 Day Price Change$ -0.24
21 Day Percent Change-7.41%
30 Day Price Change$ -0.40
30 Day Percent Change-11.76%
Month to Date Price Change$ -0.16
Month to Date Percent Change-5.06%
Quarter to Date Price Change$ 0.47
Quarter to Date Percent Change18.58%
180 Day Price Change$ -1.69
180 Day Percent Change-36.03%
200 Day Price Change$ -4.64
200 Day Percent Change-60.74%
Year to Date Price Change$ 0.47
Year to Date Percent Change18.58%

Lisata Therapeutics Inc. (LSTA) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.30
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio12.10
Leverage Ratio1.10
Quick Ratio11.80
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-0.30
Enterprise Value$ -51,402,948
Price to Sales0.00
Price to Free Cash-0.90
PE High Last 5 Years4.70
Price To Book0.30
Price To Cash Flow0.00
PE Low Last 5 Years-1.60
Price to Tangible Book0.30
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-66.54
Return on Equity-70.73
Return on Capital-64.14

Lisata Therapeutics Inc. (LSTA) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorGrant Thornton LLP
CEODavid J. Mazzo
Emplyoees27
Last AuditUQ
CIK0000320017
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address110 Allen Road
2nd Floor
Basking Ridge, NJ 7920
Websitehttp://www.caladrius.com
Facsimile-
Telephone+1 908 842-0100
Emailjmenditto@caladrius.com


Your Recent History
NASDAQ
LSTA
Lisata The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.